United States (US) Predictive and Presymptomatic Testing Market (2025-2031) | Outlook, Share, Segmentation, Trends, Value, Industry, Size & Revenue, Companies, Growth, Competitive Landscape, Analysis, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Predictive and Presymptomatic Testing Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Predictive and Presymptomatic Testing Market - Industry Life Cycle

3.4 United States (US) Predictive and Presymptomatic Testing Market - Porter's Five Forces

3.5 United States (US) Predictive and Presymptomatic Testing Market Revenues & Volume Share, By Condition, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness and acceptance of predictive and presymptomatic testing in the US

4.2.2 Growing prevalence of chronic diseases driving the demand for early detection and prevention

4.2.3 Technological advancements enhancing the accuracy and accessibility of testing methods

4.3 Market Restraints

4.3.1 Regulatory challenges and evolving policies impacting the adoption of predictive and presymptomatic testing

4.3.2 Privacy concerns and ethical considerations regarding genetic testing

4.3.3 High costs associated with predictive and presymptomatic testing limiting widespread accessibility

6.1 United States (US) Predictive and Presymptomatic Testing Market, By Condition

6.1.1 Overview and Analysis

6.1.2 United States (US) Predictive and Presymptomatic Testing Market Revenues & Volume, By Condition, 2021- 2031F

6.1.3 United States (US) Predictive and Presymptomatic Testing Market Revenues & Volume, By Breast and Ovarian Cancer, 2021- 2031F

6.1.4 United States (US) Predictive and Presymptomatic Testing Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.1.5 United States (US) Predictive and Presymptomatic Testing Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F

6.1.6 United States (US) Predictive and Presymptomatic Testing Market Revenues & Volume, By Multiple Endocrine Neoplasia Type - 2, 2021- 2031F

6.1.7 United States (US) Predictive and Presymptomatic Testing Market Revenues & Volume, By Haemochromatosis, 2021- 2031F

7.1 United States (US) Predictive and Presymptomatic Testing Market Export to Major Countries

7.2 United States (US) Predictive and Presymptomatic Testing Market Imports from Major Countries

8.1 Number of approved predictive and presymptomatic testing technologies in the US market

8.2 Percentage increase in healthcare providers offering predictive and presymptomatic testing services

8.3 Rate of integration of predictive and presymptomatic testing into routine healthcare screenings

8.4 Patient satisfaction levels with the accuracy and reliability of predictive and presymptomatic testing

8.5 Adoption rate of genetic counseling services alongside predictive and presymptomatic testing.

9.1 United States (US) Predictive and Presymptomatic Testing Market Opportunity Assessment, By Condition, 2021 & 2031F

10.1 United States (US) Predictive and Presymptomatic Testing Market Revenue Share, By Companies, 2024

10.2 United States (US) Predictive and Presymptomatic Testing Market Competitive Benchmarking, By Operating and Technical Parameters